抗体产品
Search documents
山东兽药巨头信得科技冲刺IPO
Sou Hu Cai Jing· 2026-02-24 04:25
------广告------ 动物保健行业头部企业,中国禽用兽用生物制品排名第三的供应商,2025年收入利润双增的信得科技赴港上市。 智通财经APP了解到,近日信得科技向港交所主板递交上市申请书,工银国际、中泰国际为其联席保荐人。该公司是中国领先的动物 保健企业,根据灼识咨询的资料,以2024年收入计,该公司以1.4%的市场份额在中国动物保健市场中排名第九,并以7.9%的市场份额 在中国禽用兽用生物制品市场排名前三。 从业务上看,该公司经营兽用生物制品,其中包括疫苗产品、抗体产品及转移因子、化药制剂、饲料及饲料添加剂及中兽药产品。疫 苗产品占收入大头,2024年及2025年前9月该产品收入保持增长,收入份额分别为48.5%及53.8%,其次化药制剂,产品收入也呈增长趋 势,期间收入份额分别为20.3%及16%。此外, 2025年前9月,抗体产品、转移因子、饲料及饲料添加剂及中兽药产品收入份额分别为 7.6%、7.7%、5.7%及2.8%。 | | | 截至12月31日止年度 | | | | 截至9月30日止九個月 | | | | --- | --- | --- | --- | --- | --- | --- ...
信得科技:中国动物保健行业排名第九,打造“海外市场”增长点
Zhi Tong Cai Jing· 2026-02-24 03:31
动物保健行业头部企业,中国禽用兽用生物制品排名第三的供应商,2025年收入利润双增的信得科技赴港上市。 | | | 截至12月31日止年度 | | | | 截至9月30日止九個月 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | 2023年 | | 2024年 | | 2024年 | | 2025年 | | | 人民幣千元 | % - | 人民幣千元 | % | 人民幣千元 | 6 | 人民幣千元 | | 獸用生物製品 | | | | | | | | | 疫苗產品 | 464.952 | 47.2 | 476.267 | 48.5 | 346.917 | 49.5 | 471.332 | | 抗體產品 | 96,414 | 9.8 | 86,230 | 8.8 | 63,470 | 9.1 | 66,797 | | 轉移因子 | 64.948 | 6.6 | 68,033 | 6.9 | 47.317 | 6.8 | 67.282 | | 小計 | 626.314 | 63.6 | 630.530 | 64.2 | 457.704 | 65.4 ...
扩投资增动能,拱墅产业提质向新
Hang Zhou Ri Bao· 2025-06-19 02:31
Core Insights - The article highlights the rapid growth of high-tech industry investment in the Gongshu District of Hangzhou, with a year-on-year increase of 49% from January to May, leading the city in this sector [3][4]. Group 1: Investment and Projects - The East China Pharmaceutical Biomedicine Innovation Manufacturing Center project has a total investment plan of 2 billion yuan, with phase one investment completion at 140 million yuan and a cumulative investment of 320 million yuan so far [4]. - The project aims to establish facilities for the commercialization of antibody-drug conjugates (ADCs) and related quality control and research laboratories, addressing the industrialization needs in the biopharmaceutical field [4][5]. - The Gongshu District is actively promoting the construction of a biopharmaceutical innovation ecosystem, targeting the establishment of a globally influential biopharmaceutical industry transformation hub by 2035 [5]. Group 2: Government Initiatives and Ecosystem Development - The district government plans to implement 558 investment projects this year, aiming for over 7.57 billion yuan in investment, while also stimulating private investment through new cooperation mechanisms [6]. - A high-energy innovation platform matrix is being constructed, represented by several research institutes, to support technological innovation and talent development [6][7]. - The establishment of a "three-circle linkage" innovation ecosystem around universities is designed to enhance innovation capabilities and connect various innovation spaces, incubators, and technology parks [7].